ISO 13485:2016
DEVICE DEVELOPMENT

Biocompatibility in Medical Device Development: Latest Insights

Biocompatibility in Medical Device Development: Latest Insights

Introduction to Biocompatibility of Medical Devices

Biocompatibility is a critical aspect of medical device development.In the realm of medical device design and development, understanding the interaction between these devices and the human body is critical. Ensuring the safety and effectiveness of medical devices is paramount, with biocompatibility playing a pivotal role. Recent medical device developments in risk assessment, nanomaterials, degradation, sterilization, and toxicological screening have revolutionized the evaluation of biocompatibility in developing medical devices. This article delves into the essential facets of biocompatibility assessment, the latest standards updates, and the integration of new approach methodologies (NAMs) in the evolution of medical technology.

Understanding Biocompatibility

1.1 Categorization of Device Contact

When designing medical devices, categorizing the device according to its intended use and contact nature with the human body is essential. Devices are classified as surface devices, external communicating devices, implant devices, or materials for use in medical devices. The design of medical devices takes into account specific biocompatibility considerations for each category, focusing on the contact degree and potential exposure.

1.2 Duration and Frequency of Contact

The duration and frequency of contact are critical elements in the biocompatibility assessment during medical device product development. Devices intended for long-term implantation are subject to more stringent testing compared to those used for short-term or occasional contact. Medical product development protocols are tailored based on the intended duration and frequency of device usage, ensuring safety and compatibility.

1.3 Intended Population

Biocompatibility assessments in medical device design and development also take into account the intended patient population. Medical devices used in pediatric, geriatric, or immunocompromised groups often undergo more rigorous testing due to the diverse sensitivities and responses to materials, which is a key consideration in developing medical devices.

Chemical Characterization

2.1 Nature of Contact

In medical device product development, the nature of contact between the device and the human body is a crucial consideration for biocompatibility. Determining whether the device has direct or indirect contact with bodily fluids, tissues, or systemic circulation is vital in assessing the potential risks associated with leachables and extractables during the medical product development process.

2.2 Chemical Characterization

Chemical characterization is a fundamental step in assessing biocompatibility for a medical device design company. It involves identifying and quantifying the materials and chemicals used in the device. Medical device design engineering utilizes advanced analytical techniques and equipment to detect any potentially toxic or harmful substances.

Risk Assessment

3.1 ADME (Absorption, Distribution, Metabolism, Excretion)

The ADME properties of materials used in medical devices are essential for biocompatibility assessment in medical device design and development. Understanding how these materials are absorbed, distributed, metabolized, and excreted by the body is crucial in determining their potential risks and effects, which is a central concern in the ongoing medical device developments.

3.2 CMR/ED Assessment

In the realm of medical device design and development, assessing the potential for carcinogenic, mutagenic, or reprotoxic (CMR) and endocrine-disrupting (ED) effects is a cornerstone of risk assessment. Devices with materials that exhibit these hazardous properties may pose significant health risks, necessitating meticulous evaluation in line with the latest medical device developments.

Toxicological Screening

4.1 Update of ISO 10993-17:2023

The ISO 10993 series, a cornerstone in medical device design and development, offers guidelines for evaluating the biocompatibility of medical devices. In 2023, adherence to these standards, including the critical ISO 13485, remains a key focus for those developing medical devices. ISO 10993-17. The ISO 10993 series, pivotal in medical device design and development, was updated to address the assessment of potential toxicological hazards. This revision provides comprehensive guidance on CMR and ED properties, thereby enhancing the safety evaluation of medical devices in line with ISO 13485 requirements.

4.2 Toxicological Screening Limit (TSL)

New Approach Methodologies (NAMs), such as in silico modeling, in vitro testing, and high-throughput screening, have minimized the reliance on animal testing and expedited the evaluation process. NAMs are now a cornerstone in the development of medical devices, ensuring accuracy and efficiency in biocompatibility assessment. Calculating the margin of safety (MOS) is an essential process in the biocompatibility assessment within medical device design and development. MOS, the ratio of the TSL or TCL to the actual exposure level, offers a measure of safety. A higher MOS indicates a larger safety margin, reinforcing the confidence in the biocompatibility of medical device developments.

In the sphere of developing medical devices, the toxicological screening limit (TSL) is a critical parameter in biocompatibility assessment. It signifies the maximum allowable exposure to potentially toxic substances, making the determination of TSL for each material a fundamental aspect of medical device design and development for risk mitigation.

Deriving Tolerable Intake (TI) and Tolerable Contact Levels (TCL)

5.1 Deriving Tolerable Intake (TI)

Deriving Tolerable Contact Levels (TCL) is another crucial step in medical device design and development. TCL represents the allowable contact levels for materials and takes into account factors such as the nature and duration of contact, as well as the intended population. By considering TCL alongside TI, developers can ensure the safety and biocompatibility of medical devices for their intended users.

Calculating the Margin of Safety (MOS) is an essential process in the biocompatibility assessment of medical devices. MOS, which is the ratio of the TSL or TCL to the actual exposure level, provides a measure of safety. A higher MOS indicates a larger safety margin, instilling confidence in the biocompatibility of medical device developments.

The adoption of New Approach Methodologies (NAMs) has revolutionized the field of medical device design and development. These innovative techniques, including in silico modeling, in vitro testing, and high-throughput screening, have minimized the reliance on animal testing and expedited the evaluation process. NAMs are now a cornerstone in the development of medical devices, ensuring accuracy and efficiency in biocompatibility assessment.

5.2 Tolerable Contact Levels (TCL)

Deriving Tolerable Contact Levels (TCL) is another crucial step in medical device design and development. TCL represents the allowable contact levels for materials and takes into account factors such as the nature and duration of contact, as well as the intended population. By considering TCL alongside TI, developers can ensure the safety and biocompatibility of medical devices for their intended users.

Calculating the Margin of Safety (MOS) is an essential process in the biocompatibility assessment of medical devices. MOS, which is the ratio of the TSL or TCL to the actual exposure level, provides a measure of safety. A higher MOS indicates a larger safety margin, instilling confidence in the biocompatibility of medical device developments.

The adoption of New Approach Methodologies (NAMs) has revolutionized the field of medical device design and development. These innovative techniques, including in silico modeling, in vitro testing, and high-throughput screening, have minimized the reliance on animal testing and expedited the evaluation process. NAMs are now a cornerstone in the development of medical devices, ensuring accuracy and efficiency in biocompatibility assessment.

Calculating Margin of Safety (MOS)

Calculating the margin of safety (MOS) is an essential process in the biocompatibility assessment within medical device design and development. MOS, the ratio of the TSL or TCL to the actual exposure level, offers a measure of safety. A higher MOS indicates a larger safety margin, reinforcing the confidence in the biocompatibility of medical device developments.

New Approach Methodologies (NAMs)

The field of medical device design and development has been revolutionized by advancements in biocompatibility assessment, particularly through the adoption of new approach methodologies (NAMs). These cutting-edge techniques, integral to developing medical devices, minimize the reliance on animal testing and expedite the evaluation process. NAMs, which include in silico modeling, in vitro testing, and high-throughput screening, are becoming a cornerstone in medical device developments.

Conclusion

Biocompatibility assessment is a critical component in the medical device design and development process, involving a comprehensive analysis that takes into account factors like device categorization, nature of contact, and the duration and frequency of use. With the recent update of ISO 10993-17:2023 and the implementation of NAMs, the process has been refined to enhance accuracy and efficiency in medical device developments.

As the sector progresses, the commitment to the safety and biocompatibility of these devices is paramount, offering significant benefits to patients and healthcare providers. By upholding stringent biocompatibility standards and adopting innovative medical technology testing methods, the industry is poised to further elevate patient care and the advancement of medical devices.

Post New Nectar logo building
LEARN MORE ABOUT US
Nectar is an award-winning design & engineering consultancy with a specialization in medical device development. We are proudly 13485 certified, we adhere to the highest industry standards. Nectar has been an industry leader in Southern California for over 25 years. Our proven user-centered design process has facilitated the successful launch of hundreds of products in the market.
Nectar logo color
SIGN UP FOR THE NEWSLETTER

The news you need to stay on top of cutting edge medical product development.

By subscribing, you acknowledge and agree to Nectar’s Terms of Use and Privacy Policy.

FAQs

What is the significance of ISO 10993-17:2023 in biocompatibility assessment?

ISO 10993-17:2023 is a crucial standard that provides comprehensive guidance on the assessment of potential toxicological hazards associated with medical devices. It specifically addresses the evaluation of carcinogenic, mutagenic, and reprotoxic (CMR) properties, as well as endocrine-disrupting (ED) effects. This updated standard enhances the safety evaluation process by providing specific guidelines for toxicological screening, which is vital in ensuring the biocompatibility of medical devices.

How do new approach methodologies (NAMs) impact biocompatibility assessment in medical device development?

New approach methodologies (NAMs) have transformed the biocompatibility assessment landscape by reducing the reliance on traditional animal testing methods. NAMs utilize innovative techniques such as in silico modeling, in vitro testing, and high-throughput screening to expedite the evaluation process. They not only save time and resources but also align with ethical concerns related to animal testing. NAMs offer more accurate and efficient ways to assess the biocompatibility of medical devices, contributing to safer and more rapidly developed healthcare solutions.

Why is understanding the nature of contact with the human body essential in biocompatibility assessment?

The nature of contact between a medical device and the human body is a critical consideration in biocompatibility assessment. It helps determine the potential risks associated with leachables and extractables from the device’s materials. Whether the contact is direct or indirect with bodily fluids, tissues, or systemic circulation has a significant impact on the evaluation process. Understanding this nature of contact allows for tailored testing protocols, ensuring the safety and effectiveness of the medical device in its intended application.

Nectar logo color

We are an ISO 13485-certified design and engineering firm based in Southern California, specializing in the development of cutting-edge medical devices.

Our Services
Mechanical engineering, Industrial Design, Software
Firmware, Usability, User interface design, Regulatory

Acumen IQ device in use

Related Blogs

Aluminum Biocompatibility: Safety in Medical and Industrial Applications

This article explores aluminum's biocompatibility in medical and industrial applications, highlighting its suitability, benefits, and considerations for use in various contexts, offering valuable insights for engineers and designers.

Read Now

ISO 13485:2016 Certification and MDSAP: Nectar’s Pledge to Medical Device Quality Excellence

This article explains the importance of Nectar's ISO 13485:2016 certification, ensuring quality management in medical device design and development to meet strict regulatory standards for safe and effective products.

Read Now

ISO 14971 and pFMEA: Regulatory Expectations in Medical Device Development

Having an idea for a medical device that can change the world is great, but is only the beginning. Make sure you understand the regulatory requirements.

Read Now

Navigating Design Transfer in Medical Devices with IEC 60601

Plan for an effective design transfer process to successfully transfer your product into a viable manufactured good that can pass quality assurance tests.

Read Now
image 65

Darren Saravis

CEO

Darren is an accomplished, dynamic leader who founded Nectar, X-Naut, and BreathDirect. He is committed to improving the world through the synthesis of technology, science, and art. Under Darren’s leadership, Nectar is leveraging the latest advances in cutting-edge technology to transform medical device development and design. As part of his

image 65 (1)

Steven Wells Ph.D.

Director of Operations

Dr. Steve Wells holds a critical role in steering Nectar’s operations and defining its strategic direction. His impactful leadership has established a clear course for the company’s success. He has revitalized the company with a passion for maximizing impact through expert resource utilization since taking the helm in 2020. Steve has boosted Nectar’s portfolio, streamlined processes, and reinvigorated its innovation agenda, all with the goal of developing life-saving and impactful products. His background in senior leadership roles at Georg Fischer and his people-focused, results-driven leadership style make him an invaluable asset to our team. Steve’s extensive knowledge in chemistry, biocompatibility, and biology only adds to his value as a team member.

image 65 (2)

Nellie Roque

Director of Finance and Accounting

Nellie Roque is a seasoned professional with over 17 years of experience in the fields of accounting, human resources, and payroll. She has a wide range of experience, having worked in industries such as manufacturing, software, and non-profit organizations. Nellie holds a Bachelor’s degree in Business Administration and Accounting, demonstrating her strong foundation in financial management and human resource practices. Throughout her career, Nellie has gained extensive knowledge and expertise in these areas, making her a valuable asset to any organization.
image 65 (3)

John Duval

Principal Engineer

John is a true asset to Nectar, having been a founding member and instrumental in shaping the company’s portfolio and establishing its reputation for engineering excellence. With over 30 patents and numerous design awards to his name, John is a master of product architecture and subsystem integration, as well as design for manufacture, mechanisms, and root cause analysis. His passion for creating simple and holistic solutions that take into account a wide range of variables is evident in his work and has made him a valuable member of the Nectar team.
image 65 (4)

Aaron Gifford

Principal Engineer

With a wealth of experience as a medical device developer, Aaron is a valuable addition to the Nectar team. His expertise in transferring medical devices and IVD instruments to production is unmatched, and his 25 years of professional engineering experience speaks to his expertise. At Nectar, Aaron plays a crucial role in ensuring regulatory compliance throughout product development and manages projects with skill and precision. His recent leadership in the development of the critical care Covid EUA BDR-19™ ventilator is a testament to his abilities, and his 13 patents in the medical device space further highlight his contributions to the field.
image 65 (5)

Larry Larson

Director of Hardware and Firmware Engineering 

Larry Larson is a highly experienced engineering professional who has served as Nectar’s Director of Engineering for several years. He has extensive experience in leading, overseeing, and managing the design and development of innovative products, and has been involved in 70 unique product design cycles to date. With a deep understanding of highly regulated industries such as medical and aerospace devices, Larry has been instrumental in bringing cutting-edge technologies to market and delivering solutions that meet the needs of his clients. He has a passion for engineering and is dedicated to advancing the field by delivering products that are safe, effective, and of the highest quality.
image 65 (6)

Adam Marten

Senior Mechanical Engineer

Adam Marten has worked in the aerospace and consumer products industries since 2006 with lead engineering experience in conceptual design, product development, analysis and performance qualification testing. Adam has experience leading a range of technical projects, including multiple structural analyses for military and aerospace applications. He has also worked directly with engineering teams to develop medical devices and laboratory instrumentation.

image 65 (7)

James Wilkin

Industrial Design Manager

James is a seasoned professional with over seven years of experience at Nectar, where he brings his expertise in industrial design, user interface, and user experience to the table. With a background in the highly competitive automotive industry, working for heavyweights like Daimler and Tesla, James is a true asset to the Nectar team. He is responsible for ensuring that the company adheres to user-centered design best practices, and he works closely with clients and partners on crucial human factors strategies for FDA submissions and the overall usability engineering process. James’ achievements in this field speak to his exceptional skills and dedication to the work he does.
image 65 (8)

Rejsa Kuci

Business Development Coordinator

Rejsa is a dynamic force in driving sales and acquiring new projects at Nectar, where she excels in seamlessly aligning the Sales and Operations teams. Holding a prestigious double degree from the Rochester Institute of Technology in Management and Multimedia, Rejsa brings a wealth of experience to her role as a Project Manager, Digital Marketing Strategist, and Creative Lead. With over four years of expertise in the digital world, Rejsa is not only highly skilled but also enthusiastic about following the ISO 13485 path to ensure successful project completion. Her ability to effectively bridge the gap between Sales and Operations, combined with her passion for driving projects forward, makes her an invaluable asset to the Nectar team.
image 65 (9)

Belen Quintero

Associate Project Manager

Belen is a project manager at Nectar who brings a wealth of experience and expertise to her role. With a strong background in Mathematics and Philosophy from the University of California, Riverside, she has honed her skills in a variety of industries including healthcare ,education, food manufacturing, and engineering. Belen’ success as a project manager is due in large part to her ability to align projects with business goals, clearly define project needs, lead cross-functional teams, and effectively communicate results to stakeholders. With her proven track record of success, Belen is a valuable asset to the Nectar team and a key player in driving the company’s projects forward.
image 65 (10)

Erjon Ameti

Mechatronics Engineer

Erjon Ameti is a highly knowledgeable Mechatronics Engineer with a wealth of experience in both academic settings and startup environments. With a strong background in electronics, robotics, and 3D modeling, he possesses a unique combination of skills that allow him to excel in the fields of automation systems and mechatronics. Over the past five years, Erjon has honed his expertise in product development and industrial automation, emerging as a leading authority in his field. Currently, Erjon works at Nectar as a hardware engineer, where he is responsible for documentation, CAD design, and electronics in general. He has been involved in the entire process of Nectar engineering, bringing his expertise and experience to the forefront of the company’s success.
image 65 (11)

Redon Berisha

Electronics Engineer

Redon is a highly skilled engineer with a passion for technology and innovation. He has a background in mechatronics, which has given him a strong foundation in electronics, including electronic design, PCB design, and cable design. Redon excels in the critical components of the design process, including documentation for assemblies, testing, debugging, and ensuring each project is completed to the highest standard. At Nectar, he plays a crucial role in the creation of cutting-edge technology, bringing his unique vision to life and making him a valuable member of the team. With his technical expertise and creative vision, Redon is a leader in the field of electronic design.
image 65 (12)

Kerry Eiss

Clinical Expert - RN, BSN, CLNC

With over two decades of experience in healthcare innovation, Kerry has been instrumental in transforming patient care and improving patient outcomes across the globe. Her extensive knowledge and expertise in the cardiovascular and cardiothoracic operating room, as well as her experience in emergency medicine, geriatrics, pediatric psychiatry, and main OR, make her a versatile and valuable member of the team. From small hospitals to large teaching institutions, Kerry’s 20 years of experience with patient documentation, including the use of EPIC, Cerner, and Meditech electronic charting systems, have positioned her as a leader in her field. Her recent involvement in helping transition the Providence St. Vincent Medical Center’s Cardiac Surgery program from paper charting to electronic documentation further underscores her commitment to advancing the healthcare industry.

image 65 (13)

Flaka Brahimi

Marketing Manager

Flaka, a highly skilled professional with a background in Architecture and Spatial Planning from the University of Business and Technology in Pristina, holds a dual role at Nectar as both the Marketing Project Manager and a valuable member of the Business Development team. In her role as Marketing Project Manager, she is responsible for overseeing the development and execution of marketing strategies and as a member of the Business Development team, she actively contributes to the growth of the company by assisting in the creation of impactful marketing tactics. With her diverse background and expertise, Flaka plays a crucial role in ensuring the success of Nectar’s projects.
image 65 (14)

Brayton Hammerli

User Experience Designer

Brayton is a multi-disciplinary designer with a A.A in Studio Arts and a B.S in Industrial Design from California State University Long Beach. As a user experience designer, Brayton specializes in usability evaluations, user research, feedback studies, GUI design, mobile app design, human factors evaluations, and formative studies. In his free time, Brayton enjoys outdoor activities such as hiking, mountain biking as well as other creative pursuits. He approaches problems with a solution-focused mindset and enjoys exploring ideas. 
image 65 (15)

Stephanie Rodriguez

Accounting Coordinator

Stephanie Rodriguez is a highly experienced administrative professional with over 10 years of expertise across a diverse range of industries, including contract manufacturing, financial and wealth management, and the medical field. She holds a Bachelor’s degree in Humanities from Northern Arizona University. As a valued member of the Nectar team, Stephanie plays an integral role in supporting the engineering teams by acquiring materials and parts for the prototype phase of our clients’ projects. She also assists the Director of Accounting by issuing purchase orders and provides project managers with accurate data to effectively manage and track budgets for each stage of the statement of work. Stephanie’s knowledge and skills, combined with her dedication and drive, make her an asset to Nectar and a key player in ensuring the successful completion of our projects.
image 65 (16)

Toska Ukaj

Scientific Content Writer

Toska Ukaj is a gifted writer who brings a wealth of expertise and passion to Nectar. With a background in medical science and years of experience producing high-quality scientific and medical publications, Toska’s writing skills are unparalleled. She boasts an excellent educational record, advanced interpersonal skills, and a deep passion for healthcare. As Nectar’s writer, Toska consistently produces clear, concise pieces that can be easily understood by the public and truly captures the essence of Nectar’s mission. With her exceptional writing abilities and commitment to healthcare, Toska is an invaluable asset to the Nectar team.
image 66

Sean Wells

Mechanical R&D Technician

Sean plays a critical role at Nectar. He has a wide range of skills that help keep the company and equipment running. His background in machine and building maintenance means he has skilled hands ready for anything. Sean runs our lab equipment including 3D printers and a laser cutter. He also helps with complex project builds, assemblies, and testing.
image 65 (18)

Jonathan Cantera

Quality Manager

Jonathan at his core is a Human Factors Engineer with his M.S. in Human Factors and Minor in Sociology from California State University of Long Beach. At Nectar, Jonathan is responsible for managing and maintaining the company’s ISO 13485 Quality Management System keeping in compliance with US and international regulations for product development. Jonathan’s role ensures each department is in compliance every step of the design process, making him a critical Nectar team member. Jonathan’s Human Factors background also allows him to aid in user research, feedback sessions, usability evaluations, and formative studies such as risks assessments. When he’s not in the office, Jonathan enjoys film photography, and reading.
Vessa Hyseni Purchasing Manager

Vesa Hyseni

Purchasing Manager

Vesa is a skilled Purchasing Manager with a strong focus on procurement strategies and vendor management. With a track record of successfully leading procurement teams, Vesa excels in optimizing procurement processes, consistently striking a balance between quality assurance and cost-effectiveness. Her ability to identify cost-saving opportunities and manage supplier relationships effectively makes her an indispensable asset to Nectar.
Uran Cabra Engineer

Uran Çabra

Software Engineer

Uran Çabra, with a background in Mechatronic Systems Engineering, has been working on Embedded Systems, specifically on IoT product development. His responsibilities include firmware development and electronics design and testing. He holds a master’s degree in Electrical Engineering with a focus on Autonomous Mobile Robotics.
Sarah Clark UX UI Designer

Sarah Clark

Industrial Designer

Sarah has a background in fine art & graphic design with a B.S in Industrial Design from California State University Long Beach. As a user experience designer her specialties include: keen aesthetics, creative problem solving, a detail oriented approach to research, and improving user journeys within complex experiences.